Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Generics segment includes a retail and institutional portfolio of over 270 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Ticker SymbolAMRX
Company nameAmneal Pharmaceuticals Inc
IPO dateNov 18, 2009
CEOMr. Chintu Patel
Number of employees8100
Security typeOrdinary Share
Fiscal year-endNov 18
Address400 Crossing Boulevard, 3rd Floor
CityBRIDGEWATER
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code08807
Phone19089473120
Websitehttps://amneal.com/
Ticker SymbolAMRX
IPO dateNov 18, 2009
CEOMr. Chintu Patel
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data